Cytoreductive treatment and kidney vascular damage in patients with chronic myeloproliferative neoplasms

Kidney Int. 2024 Apr;105(4):890. doi: 10.1016/j.kint.2024.01.008.

Authors

Ivan Krecak¹, Marko Lucijanic²

Affiliations

¹ Department of Internal Medicine, General Hospital of Sibenik-Knin County, Sibenik, Croatia; University of Applied Sciences, Sibenik, Croatia; Faculty of Medicine, University of Rijeka, Rijeka, Croatia. Electronic address: krecak.ivan@gmail.com.
² Division of Hematology, University Hospital Dubrava, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia.

PMID: 38519241
DOI: 10.1016/j.kint.2024.01.008

No abstract available

Publication types

Letter

MeSH terms

Cytoreduction Surgical Procedures
Humans
Kidney
Kidney Diseases*
Kidney Neoplasms*
Myeloproliferative Disorders* / complications
Neoplasms*